ERM proteins and Cdk5 in cellular senescence

Hai-Su Yang1, Kamilah Alexander, Pedro Santiago

  • 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

Cellular senescence, a tumor-suppressive process, involves cell cycle exit and characteristic morphology. New findings reveal retinoblastoma protein (pRb) and cdk5 signaling regulate ezrin, a key protein in the senescent cell shape change.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cellular senescence is a crucial tumor-suppressive mechanism.
  • Senescence is characterized by irreversible cell cycle arrest, altered morphology, and SA-beta-gal expression.
  • Mechanisms driving senescence induction and phenotype remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cellular senescence.
  • To elucidate the role of the retinoblastoma protein (pRb) in senescence.
  • To identify signaling pathways involved in the senescent cell shape change.

Main Methods:

  • Studied the effect of active pRb expression on ezrin.
  • Investigated cdk5-mediated phosphorylation of ezrin.
  • Assessed the role of cdk5 in SA-beta-gal expression and actin polymerization.

Main Results:

  • Active pRb expression induces ezrin expression and alters its localization.
  • pRb stimulates cdk5-mediated ezrin phosphorylation, leading to membrane association and cell shape changes.
  • Increased cdk5 activity in senescent cells is essential for SA-beta-gal expression and actin polymerization.

Conclusions:

  • pRb links to cytoskeletal regulation via ezrin and cdk5 in senescent cells.
  • Cdk5 activity is critical for establishing the senescent phenotype and morphology.
  • These findings reveal novel pathways in senescence induction and regulation of tumor growth.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...